A real-world evaluation of a tertiary care childhood obesity intervention to reduce metabolic risk in a hard-to-reach urban population

Table 3 The number and percentage of participants with abnormal measures at baseline and follow-up and the number and percentage with normalized measures at follow-up of those with abnormal baseline measures

Measure	Abnormal at Baseline N (%)	Normalized measure at follow-up of those with abnormal measure at baseline N (%)	Abnormal at Follow-up	p value*
Waist Circumference^a	133 (92.4%)	10 (7.5%)	127 (88.2%)	p = 0.180
Blood Pressure^b
Systolic blood pressure	64 (44.4%)	33 (51.6%)	55 (38.2%)	p = 0.289
Diastolic blood pressure	20 (13.9%)	18 (90.0%)	15 (10.4%)	p = 0.473
Lipid Levels^c
Total cholesterol	67 (46.5%)	16 (23.9%)	65 (45.1%)	p = 0.856
High-density lipoprotein	48 (33.3%)	22 (45.8%)	38 (26.4%)	p = 0.121
Low-density lipoprotein	50 (34.7%)	13 (26.0%)	54 (37.5%)	p = 0.585
Triglycerides	37 (25.7%)	18 (48.6%)	39 (27.1%)	p = 0.871
Fasting Glucose^d	7 (4.9%)	6 ((85.7%)	3 (2.1%)	p = 0.289
Presence of 3 or more components of the metabolic syndrome^e	44 (30.6%)	22 (50.0%)	39 (27.1%)	p = 0.522

*p-values refer to McNemar tests
^aWaist circumference ≥ 90th percentile for age and sex was defined as abnormal [14]
^bHypertension was defined as SBP or DBP ≥ 90th percentile for age, sex, and height [14]
^cAbnormal lipid levels were defined as: TC ≥ 160 mg/dL; HDL ≤ 40 mg/dL; LDL ≥ 110 mg/dL; and TG ≥ 110 mg/dL for those 12 yrs. and older or ≥ 90th percentile for age and sex [14]
^dAbnormally high fasting glucose level was defined as ≥110 mg/dL [14]
^eDefined as presence of 3 or more of the following: increased waist circumference, systolic or diastolic hypertension, a high TG level, a low HDL level, or elevated fasting glucose concentration

ISSN: 1471-2431